CAMP4 Therapeutics Corp’s recent filing unveils that its 10% Owner 5AM Partners VI, LLC acquired Company’s shares for reported $4.5 million on Sep 11 ’25. In the deal valued at $1.53 per share,2,941,176 shares were bought. As a result of this transaction, 5AM Partners VI, LLC now holds 2,941,176 shares worth roughly $19.85 million.
Then, Polaris Management Co. VII, L. bought 1,307,189 shares, generating $1,999,999 in total proceeds. Upon buying the shares at $1.53, the 10% Owner now owns 2,825,500 shares.
Before that, Nashat Amir bought 1,307,189 shares. CAMP4 Therapeutics Corp shares valued at $1,999,999 were divested by the Director at a price of $1.53 per share. As a result of the transaction, Nashat Amir now holds 2,825,500 shares, worth roughly $19.07 million.
Cantor Fitzgerald initiated its CAMP4 Therapeutics Corp [CAMP] rating to an Overweight in a research note published on October 02, 2025; the price target was $7. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid September from “an Overweight” to “a Neutral”. Wedbush began covering CAMP with “an Outperform” recommendation on May 27, 2025. William Blair started covering the stock on November 05, 2024. It rated CAMP as “an Outperform”.
Price Performance Review of CAMP
On Monday, CAMP4 Therapeutics Corp [NASDAQ:CAMP] saw its stock jump 4.01% to $6.75. Over the last five days, the stock has gained 84.93%. CAMP4 Therapeutics Corp shares have fallen nearly -20.40% since the year began. Nevertheless, the stocks have risen 29.31% over the past one year. While a 52-week high of $9.71 was reached on 12/15/25, a 52-week low of $1.30 was recorded on 06/20/25.
Levels Of Support And Resistance For CAMP Stock
The 24-hour chart illustrates a support level at 6.22, which if violated will result in even more drops to 5.69. On the upside, there is a resistance level at 7.07. A further resistance level may holdings at 7.39.
How much short interest is there in CAMP4 Therapeutics Corp?
A steep rise in short interest was recorded in CAMP4 Therapeutics Corp stocks on 2025-11-28, growing by 18688.0 shares to a total of 0.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 0.4 million shares. There was a rise of 4.49%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 05, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $18 price target.
